Clinical trial
Omega-3 Fatty Acid Treatment in Multiple Sclerosis
NCT00360906 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omega-3 Fatty Acid Treatment in Multiple Sclerosis
- Lead sponsor
- Haukeland University Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- July 31, 2008
- Enrollment
- 100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing-remitting multiple sclerosis